Swati c. Joshi
Dr. Sarika Shrivastava
- Professor, Department of Pharmacy, Sanjeev Agrawal Global Educational University, Bhopal, Madhya Pradesh, India
- Professor, Department of Pharmacy, Sanjeev Agrawal Global Educational University, Bhopal, Madhya Pradesh, India
Abstract
Cancer disease is characterized by abnormal cell growth. Malignant growth treatments have progressed significantly, yet there is a requirement for development in particularity and feeling of dread toward foundational harmfulness. Nanotechnology is the reconciliation of nanoscience into medication by the utilization of nanoparticles. The appearance of nanoscience in disease conclusion and treatment will assist clinicians with better surveying and oversee patients and further develop the medical care framework and administrations Cytotoxic drugs can not differentiate in healthy cells and cancerous cells and produce adverse effects. The use of nanotechnologies in pharmaceuticals for therapeutic and diagnostic purposes has grown significantly in popularity. Nanotechnology in disease the board has yielded different promising results, including drug organization, quality treatment, checking and diagnostics, prescription carriage, biomarker following, medications, and histopathological imaging. The nanoscale drug conveyance, will guarantee that dangerous tissues are explicitly focused on while decreasing inconveniences. Due to their organic nature, nanomaterials can cross cell walls effortlessly. Due to their dynamic and detached focusing on, nanomaterials have been utilized in disease treatment for a long time.A thermodynamically unstable colloidal dispersion of two immiscible liquids is called a nanoemulsion. Nanoemulsion are considered as one of the most feasible nanocarriers to deliver lipophilic anticancer agents with targeted delivery. So a review on nonoemulsion in cancer therapy is presented here.
Keywords: Nanoemulsion, Cancer, Nanocarriers, Water, Inversion, Anti-cancer drugs.
[This article belongs to Research & Reviews: A Journal of Pharmaceutical Science(rrjops)]
Browse Figures
References
1) Fahr, A. Voigt’s Pharmaceutical Technology, 12th ed.; John Wiley & Sons: New York, NY, USA, 2018.
2) Demetzos, C. Pharmaceutical Nanotechnology, Fundamentals and Practical Applications; Springer: Singapore, 2016. https://link.springer.com/book/10.1007/978- 981-10-0791-0
3) Kher, C.; Kumar, S. The application of nanotechnology and nanomaterials in cancer diagnosis and treatment: A review. Cureus2022, 14, 29059. [CrossRef] 4) Karthik P, Ezhilarasi PN, Anandharamakrishnan C. Challengesassociated in stability of food grade nanoemulsions. Crit RevFood Sci Nutr. 2017. 57:1435-1450.
5) Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 2011.25:1000-1008.
6) Cheng Z, Li MY, Dey R, Chen YH. Nanomaterials for cancer therapy: current progress and perspective . J Hematol Oncol.2021;14(1):85 7) Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther. 2010;128(2):324-335
8) Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance Signal Transduct Target Ther.2018;3(1):7 9) Wang Y. Preparation of nano- and microemulsions using phaseinversion and emulsion titration methods. Master’s thesis.Massey University, Auckland, New Zealand. 2014.
10) Komaiko JS, McClements DJ. Formation of food-grade nanoemulsions using low- energy preparation methods: a review of available methods. Compr Rev Food Sci Food Saf. 2016. 15:331-352.
11) Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Potentials and challenges in self- nanoemulsifying drug delivery systems Expert Opin Drug Deliv. 2012. 9:1305-1317.
12) Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, etal. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017. 252:28-49.
13) Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery:formulation development, stability issues, basic considerations and applications. J Control Release. 2018. 270:203-225.
14) Floury J, Desrumaux A, Lardières J. Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions. Innov Food Sci Emerg Technol. 2000. 1:127-134.
15) Schultz S, Wagner G, Urban K, Ulrich J. High-pressure homogenization as a process for emulsion formation. Chem Eng Technol. 2004. 27:361-368.
16) Jafari SM, He Y, Bhandari B. Production of sub-micron emulsions by ultrasound and microfluidization techniques. J Food Eng.2007. 82:478-488.
17) Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011. 2:626-639.
18) Maa YF, Hsu CC. Performance of sonication and microfluidization for liquid-liquid emulsification. Pharm Dev Technol. 1999 4:233-240.
19) Mahdi Jafari S, He Y, Bhandari B. Nano-emulsion production by sonication and microfluidization-a comparison. Int J Food Prop. 2006. 9:475-485.
20) Jayasooriya SD, Bhandari BR, Torley P, D’Arcy BR. Effect of high power ultrasound waves on properties of meat: a review. Int J Food Prop. 2004. 7:301-319.
21) Canselier JP, Delmas H, Wilhelm AM, Abismaïl B. Ultrasound emulsification-an overview. J Dispersion Sci Technol. 2002.23:333-349.
22) Leong TSH, Wooster TJ, Kentish SE, Ashokkumar M. Minimising oil droplet size using ultrasonic emulsification. Ultrason Sonochem. 2009. 16:721-727.
23) Solè I, Pey CM, Maestro Al, González C, Porras M, Solans C, et al.Nano-emulsions prepared by the phase inversion composition method: preparation variables and scale up. J Colloid Interface Sci. 2010. 344:417-423.
24) Ishak KA, Annuar MSM. Phase inversion of medium-chain-length poly-3- hydroxyalkanoates (mcl-PHA)-incorporated nanoemulsion: effects of mcl-PHA molecular weight and amount on its mechanism. Colloid Polym Sci. 2016. 294:1969- 1981.
25) Solans C, Solé I. Nano-emulsions: formation by low-energy methods. Curr Opin Colloid Interface Sci. 2012. 17:246-254.
26) Gutiérrez JM, González C, Maestro A, Solè I, Pey CM, Nolla J.Nano-emulsions: new applications and optimization of their preparation. Curr Opin Colloid Interface Sci. 2008. 13:245-251.
27) Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nanoemulsions. Curr Opin Colloid Interface Sci. 2005. 10:102-110.
28) Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano- emulsions. Adv Colloid Interface Sci. 2004. 108-109:303-318.
29) Hu J, Johnston KP, Williams RO III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm. 2004. 30:233-245.
30) McClements DJ, Decker EA, Weiss J. Emulsion-based delivery systems for lipophilic bioactive components. J Food Sci. 2007.72:R109-R124.
31) de Oca-Ávalos JMM, Candal RJ, Herrera ML. Nanoemulsions: stability and physical properties. Curr Opin Food Sci. 2017. 16:1-6.
Research & Reviews: A Journal of Pharmaceutical Science
| Volume | 15 |
| Issue | 01 |
| Received | February 5, 2024 |
| Accepted | February 17, 2024 |
| Published | February 28, 2024 |